Compare Koninklijke Philips NV (PHG) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Nuscale Power Corporation — how do they compare? Koninklijke Philips NV trades at $25.02 (market cap $24.61B), while Nuscale Power Corporation trades at $10.78 (market cap $4.44B). The key difference: Koninklijke Philips NV is far larger — about 5.5× Nuscale Power Corporation's market cap, and Koninklijke Philips NV pays a 4.05% dividend while Nuscale Power Corporation pays none. Which is the better fit depends on your goals.
| PHG | SMR | |
|---|---|---|
Market Cap | $24.61B | $4.44B |
Sector | Health | Utilities |
52-Week High | $32.91 | $53.43 |
52-Week Low | $25.02 | $7.59 |
Enterprise Value | $31.21B | $3.36B |
Dividend Yield | 4.05% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $25.29, down 2.32% today, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with Q2 2026 EPS of $0.57 beating expectations of $0.40, and positive net income of $895M in 2025 reversing previous losses. Recent product launches in women's health and AI-powered medical devices demonstrate innovation momentum.
The outlook is mixed with strong fundamentals and analyst support (36% buy ratings) offset by technical weakness. Key opportunities include margin expansion and new product adoption, while risks involve cybersecurity threats and competitive pressures in healthcare technology.
SMR stock trades at $11.18, up 15.32% in the last 24 hours, with a bullish technical signal from moving averages and oscillators. The company reported a net loss of $355.79 million on $31.48 million revenue in 2025, with a negative net income margin of -3,888.7% and a high price-to-sales ratio of 272.59. Recent news highlights its cash position and potential in small modular reactors for AI energy demand.
Outlook is speculative with high growth potential from nuclear energy trends but significant execution risks. Analysts are divided, with a 50% buy rating and $11.25 consensus target. Key risks include cash burn, lack of profitability, and project delays, requiring cautious investor consideration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
